Topic

All

26
Oct
2017

VIDEO: Climbing Mount Everest to Support Cancer Research at Fred Hutch

Hi, I’m Luke Timmerman, a biotech journalist. I’m carrying my 80-pound training backpack, up and down the hills of Seattle, for a reason. I’m training to climb Mt. Everest, the highest mountain in the world, in 2018. Why do this? Of course, I love the mountains. But mostly, I’m doing it to support the top-notch research at the Fred Hutchinson...
Read More
25
Oct
2017

Richard Pops on Fighting the Opioid Painkiller Crisis

Today’s guest on “The Long Run” podcast is Richard Pops. He’s the chairman and CEO of Alkermes. He is one of the seniormost executives in the biopharma industry, having joined Alkermes as CEO back in 1991. The company is known for its technology around making long-lasting injectable drugs, especially for mass-market chronic diseases like schizophrenia and diabetes. I’ve known Pops...
Read More
11
Oct
2017

George Yancopoulos on Threading the Price Needle, and Building a Biotech to Last

George Yancopoulos, the president and chief scientific officer, started his biotech career in 1989 at Regeneron Pharmaceuticals. He’s been there ever since, and has pretty much seen it all. It was a pleasure to have him as the guest for Episode 3 of The Long Run podcast. Yancopoulos, in this recording at Regeneron offices in Tarrytown, NY, talks about how...
Read More
25
Sep
2017

Socializing After Hours: It’s How Biotech Runs, and Should Be Open to All

Back in the “Mad Men” era, there was the three-martini lunch. When boozy mid-day breaks went out of style, business executives found other ways to grease the wheels of social interaction outside of the office. Like doing deals on the golf course. There are many ways to cultivate the social connections that are a crucial step toward forming trusting relationships...
Read More